Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study
2020; Elsevier BV; Volume: 136; Issue: 1 Linguagem: Inglês
10.1182/blood.2020006941
ISSN1528-0020
AutoresDouglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina J. Kessler, Sangeetha Venugopal, Iman Makki, Qian Qin, Sirish Dharmapuri, Tomi Jun, Sheena Bhalla, Shana Berwick, Jonathan Feld, John Mascarenhas, Kevin Troy, Caroline Cromwell, Andrew Dunn, William Oh, Leonard Naymagon,
Tópico(s)COVID-19 and healthcare impacts
ResumoTremblay and colleagues asked whether patients receiving either routine anticoagulation or antiplatelet therapy for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients receiving neither therapy. After matching for existing comorbidities, this retrospective observational study finds no evidence for an effect of prediagnosis anticoagulation on mortality.
Referência(s)